106 related articles for article (PubMed ID: 25580906)
21. Evaluation of genotoxic effects of new molecules with possible trypanocidal activity for Chagas disease treatment.
Mello FV; Carvalho AS; Bastos MM; Boechat N; Aiub CA; Felzenszwalb I
ScientificWorldJournal; 2013; 2013():287319. PubMed ID: 24311974
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of new trypanocidal agents from the hybridisation of metronidazole and eugenol analogues.
Pelozo MF; Cordeiro CF; Inácio LF; de Cassia Alves Lemini R; Gonçalves Souza E Leite E; Benedetti MD; Tulha CA; Novaes RD; Caldas IS; Carvalho DT; Lavorato SN; Hawkes JA; Franco LL
Bioorg Chem; 2024 May; 146():107288. PubMed ID: 38521013
[TBL] [Abstract][Full Text] [Related]
23. Discovery of potent nitrotriazole-based antitrypanosomal agents: In vitro and in vivo evaluation.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; O'Shea IP; Wilkinson SR; Kaiser M; Chatelain E; Ioset JR
Bioorg Med Chem; 2015 Oct; 23(19):6467-76. PubMed ID: 26344593
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and biological evaluation of quinazoline derivatives as anti-trypanosomatid and anti-plasmodial agents.
Mendoza-Martínez C; Correa-Basurto J; Nieto-Meneses R; Márquez-Navarro A; Aguilar-Suárez R; Montero-Cortes MD; Nogueda-Torres B; Suárez-Contreras E; Galindo-Sevilla N; Rojas-Rojas Á; Rodriguez-Lezama A; Hernández-Luis F
Eur J Med Chem; 2015; 96():296-307. PubMed ID: 25899334
[TBL] [Abstract][Full Text] [Related]
25. A new era for chagas disease drug discovery?
Keenan M; Chaplin JH
Prog Med Chem; 2015; 54():185-230. PubMed ID: 25727705
[TBL] [Abstract][Full Text] [Related]
26. Cyclic AMP Regulates Social Behavior in African Trypanosomes.
Oberholzer M; Saada EA; Hill KL
mBio; 2015 Apr; 6(3):e01954-14. PubMed ID: 25922395
[TBL] [Abstract][Full Text] [Related]
27. Development of bis-thiazoles as inhibitors of triosephosphate isomerase from Trypanosoma cruzi. Identification of new non-mutagenic agents that are active in vivo.
Álvarez G; Martínez J; Varela J; Birriel E; Cruces E; Gabay M; Leal SM; Escobar P; Aguirre-López B; Cabrera N; Tuena de Gómez-Puyou M; Gómez Puyou A; Pérez-Montfort R; Yaluff G; Torres S; Serna E; Vera de Bilbao N; González M; Cerecetto H
Eur J Med Chem; 2015 Jul; 100():246-56. PubMed ID: 26094151
[TBL] [Abstract][Full Text] [Related]
28. Trypanosoma cruzi Infection through the Oral Route Promotes a Severe Infection in Mice: New Disease Form from an Old Infection?
Barreto-de-Albuquerque J; Silva-dos-Santos D; Pérez AR; Berbert LR; de Santana-van-Vliet E; Farias-de-Oliveira DA; Moreira OC; Roggero E; de Carvalho-Pinto CE; Jurberg J; Cotta-de-Almeida V; Bottasso O; Savino W; de Meis J
PLoS Negl Trop Dis; 2015 Jun; 9(6):e0003849. PubMed ID: 26090667
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of quinones derived from natural product komaroviquinone as anti-Trypanosoma cruzi agents.
Suto Y; Nakajima-Shimada J; Yamagiwa N; Onizuka Y; Iwasaki G
Bioorg Med Chem Lett; 2015 Aug; 25(15):2967-71. PubMed ID: 26037321
[TBL] [Abstract][Full Text] [Related]
30. Studies of genotoxicity and mutagenicity of nitroimidazoles: demystifying this critical relationship with the nitro group.
Boechat N; Carvalho AS; Salomão K; Castro SL; Araujo-Lima CF; Mello FV; Felzenszwalb I; Aiub CA; Conde TR; Zamith HP; Skupin R; Haufe G
Mem Inst Oswaldo Cruz; 2015 Jun; 110(4):492-9. PubMed ID: 26018452
[TBL] [Abstract][Full Text] [Related]
31. An Atypical Mitochondrial Carrier That Mediates Drug Action in Trypanosoma brucei.
de Macêdo JP; Schumann Burkard G; Niemann M; Barrett MP; Vial H; Mäser P; Roditi I; Schneider A; Bütikofer P
PLoS Pathog; 2015 May; 11(5):e1004875. PubMed ID: 25946070
[TBL] [Abstract][Full Text] [Related]
32. Identification and structure solution of fragment hits against kinetoplastid N-myristoyltransferase.
Robinson DA; Wyatt PG
Acta Crystallogr F Struct Biol Commun; 2015 May; 71(Pt 5):586-93. PubMed ID: 25945713
[TBL] [Abstract][Full Text] [Related]
33. VFV as a New Effective CYP51 Structure-Derived Drug Candidate for Chagas Disease and Visceral Leishmaniasis.
Lepesheva GI; Hargrove TY; Rachakonda G; Wawrzak Z; Pomel S; Cojean S; Nde PN; Nes WD; Locuson CW; Calcutt MW; Waterman MR; Daniels JS; Loiseau PM; Villalta F
J Infect Dis; 2015 Nov; 212(9):1439-48. PubMed ID: 25883390
[TBL] [Abstract][Full Text] [Related]
34. Transport proteins determine drug sensitivity and resistance in a protozoan parasite, Trypanosoma brucei.
Munday JC; Settimo L; de Koning HP
Front Pharmacol; 2015; 6():32. PubMed ID: 25814953
[TBL] [Abstract][Full Text] [Related]
35. The in vivo dynamics of antigenic variation in Trypanosoma brucei.
Mugnier MR; Cross GA; Papavasiliou FN
Science; 2015 Mar; 347(6229):1470-3. PubMed ID: 25814582
[TBL] [Abstract][Full Text] [Related]
36. Targeting Ergosterol biosynthesis in Leishmania donovani: essentiality of sterol 14 alpha-demethylase.
McCall LI; El Aroussi A; Choi JY; Vieira DF; De Muylder G; Johnston JB; Chen S; Kellar D; Siqueira-Neto JL; Roush WR; Podust LM; McKerrow JH
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003588. PubMed ID: 25768284
[TBL] [Abstract][Full Text] [Related]
37. Functional analysis of drug resistance-associated mutations in the Trypanosoma brucei adenosine transporter 1 (TbAT1) and the proposal of a structural model for the protein.
Munday JC; Tagoe DN; Eze AA; Krezdorn JA; Rojas López KE; Alkhaldi AA; McDonald F; Still J; Alzahrani KJ; Settimo L; De Koning HP
Mol Microbiol; 2015 May; 96(4):887-900. PubMed ID: 25708978
[TBL] [Abstract][Full Text] [Related]
38. Repurposing of the Open Access Malaria Box for Kinetoplastid Diseases Identifies Novel Active Scaffolds against Trypanosomatids.
Kaiser M; Maes L; Tadoori LP; Spangenberg T; Ioset JR
J Biomol Screen; 2015 Jun; 20(5):634-45. PubMed ID: 25690568
[TBL] [Abstract][Full Text] [Related]
39. Anti-
Menozzi CAC; França RRF; Luccas PH; Baptista MDS; Fernandes TVA; Hoelz LVB; Sales Junior PA; Murta SMF; Romanha A; Galvão BVD; Macedo MO; Goldstein ADC; Araujo-Lima CF; Felzenszwalb I; Nonato MC; Castelo-Branco FS; Boechat N
Molecules; 2023 Nov; 28(22):. PubMed ID: 38005183
[TBL] [Abstract][Full Text] [Related]
40. Chromenol Derivatives as Novel Antifungal Agents: Synthesis, In Silico and In Vitro Evaluation.
Zveaghintseva M; Stingaci E; Pogrebnoi S; Smetanscaia A; Valica V; Uncu L; Ch Kravtsov V; Melnic E; Petrou A; Glamočlija J; Soković M; Carazo A; Mladěnka P; Poroikov V; Geronikaki A; Macaev FZ
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
